Uses
OVIDE Lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.
Source: US FDA prescribing information
Molecule
Malathion
Cholinesterase Inhibitor
Available on request
- Presentations
- 2
- Brands
- 1
- Manufacturers
- 1
- Available from stock
- 0
Malathion is a cholinesterase inhibitor indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair. It is available as lotion for topical use. MedsAcross supplies Malathion for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Cholinesterase Inhibitor, Cholinesterase Inhibitors
- ATC classification
- P03AX03 Malathion · Ectoparasiticide, subgroup P03AX
- US FDA first approval
- 2 August 1982
- EU status
- Not recorded
- Orphan designation
- Not recorded
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Topical
- Dosage forms
- Lotion
- Identifiers
- UNII U5N7SU872WRxCUI 6606CAS 121-75-5DrugBank DB00772Q423005
Clinical information
From the regulator-approved product information. Each section names its source.
Dosing overview
Apply OVIDE Lotion on DRY hair in amount just sufficient to thoroughly wet the hair and scalp. Pay particular attention to the back of the head and neck while applying OVIDE Lotion. Wash hands after applying to scalp. Allow hair to dry naturally - use no electric heat source, and allow hair to remain uncovered. After 8 to 12 hours, the hair should be shampooed. Rinse and use a fine - toothed (nit) comb to remove dead lice and eggs. If lice are still present after 7 - 9 days, repeat with a second application of OVIDE Lotion. Further treatment is generally not necessary. Other family members should be evaluated by a physician to determine if infested, and if so, receive treatment.
Source: US FDA prescribing information
Contraindications
OVIDE Lotion is contraindicated for neonates and infants because their scalps are more permeable and may have increased absorption of malathion. OVIDE Lotion should also not be used on individuals known to be sensitive to malathion or any of the ingredients in the vehicle.
Source: US FDA prescribing information
Warnings and precautions
OVIDE Lotion is flammable. The lotion and wet hair should not be exposed to open flames or electric heat sources, including hair dryers and electric curlers. Do not smoke while applying lotion or while hair is wet. Allow hair to dry naturally and to remain uncovered after application of OVIDE Lotion. OVIDE Lotion should only be used on children under the direct supervision of an adult. If OVIDE Lotion comes into contact with the eyes, flush immediately with water. Consult a physician if eye irritation persists. If skin irritation occurs, discontinue use of product until irritation clears. Reapply the OVIDE Lotion, and if irritation reoccurs, consult a physician. Chemical burns including second-degree burns and stinging sensations may occur with the use of OVIDE Lotion. General Keep out of reach of children. Close eyes tightly during product application.
Source: US FDA prescribing information
Side effects
Malathion has been shown to be irritating to the skin and scalp. Other adverse reactions reported are chemical burns including second-degree burns. Accidental contact with the eyes can result in mild conjunctivitis. It is not known if OVIDE Lotion has the potential to cause contact allergic sensitization.
Source: US FDA prescribing information
Storage
Stored at 20° to 25°C (68° to 77°F) Flammable.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
All presentations
2 presentations of Malathion, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Malathion 0.0005 g/mL lotionTopicalGeneric name | — | US FDA | Available on request |
| Ovide 0.0005 g/mL lotionTopical | Sun Pharmaceutical IndustriesIndia | US FDA | Available on request |
Brands by market
1 brand names across 1 markets.
United States
Manufacturers
Indian manufacturers are highlighted.
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 2 August 1982 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Conditions
Conditions linked to Malathion in public data. This is not a list of approved uses, see the clinical information.
Questions and answers
Is Malathion available for export from India?
Yes, on request. MedsAcross lists 2 presentations of Malathion and sources them for licensed hospitals, importers and physicians against valid import documents. Indian manufacturers include Sun Pharmaceutical Industries.
What brand names does Malathion have?
The catalogue lists 1 brand names for Malathion, including Ovide.
Is Malathion approved by the US FDA?
Yes. The US FDA first approved Malathion on 2 August 1982, according to Drugs@FDA.
Does Malathion need cold chain shipping?
No listed presentation of Malathion is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Malathion in?
Malathion is classified under ATC code P03AX03 (Malathion).
References
- Ovide prescribing information (Sun Pharmaceutical Industries). U.S. National Library of Medicine, DailyMed. Retrieved 15 July 2026
Request Malathion for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.